International Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhinitis (ALTO)

Stallergenes Greer

Status: Terminated

Conditions: Allergic Rhinitis Due to Grass Pollens

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT02041624

ORA-PES-05-WO

Details and patient eligibility

About

The purpose of the present study is to describe patient's perception of quality of life and effectiveness of ORALAIR® over a follow-up period up to 5 years, in real-life settings.

Full description

Primary objective:

To describe the patient's perception of the impact of ORALAIR® on his/her health related generic and disease specific quality of life during the grass pollen season in real-life settings.

Secondary objectives:

• To describe the patient's perceived effectiveness of ORALAIR® in allergic rhinoconjunctivitis management in terms of disease intensity, satisfaction and rescue medication

Enrollment: 740 patients

Sex: All

Ages: 5+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient of 5 years of age and older at the date of the screening visit
• Patient with proven allergic rhino-conjunctivitis due to grass pollen
• Patient eligible for a grass-pollen Allergen ImmunoTherapy (AIT)
• Patient whose physician prescribed ORALAIR® independently of the study, before the beginning of the grass-pollen season

Exclusion criteria

• Patient participating in a clinical trial or in an epidemiological study

Trial design

740 participants in 1 patient group

allergic rhino-conjunctivitis

Description:

Patient with proven allergic rhino-conjunctivitis due to grass pollen